Picture
Dr.Shruti Bhat, Leader Pharmaceutical R&D and Expert in hiTech formulation development for over 35 different therapeutic class of drugs moeities, brings to you some highlights from current pharma and clinical research news, views and data. 

FDA Approves Novel Asthma Treatment.  USFDA recently approved the "first non-drug asthma treatment- Alair." According to the developer the procedure known as "bronchial thermoplasty" would "only be appropriate for about two million adults with severe asthma who don't get relief from existing drugs."  

The device, delivers radiofrequency energy directly to the airways, heating and reducing the thickness of lung tissue and improving users' ability to breathe ...


FDA Approves Mylan, Teva Flomax Generics.  Mylan Inc. and Teva Pharmaceutical Industries Ltd. "reported lately that, they are started selling their own versions of Flomax [tamsulosin HCl], a drug that treats enlarged prostate ...
 
Cancer Risk After Kidney Transplant Similar From All Antirejection Drugs. According to a study published in the April 29 issue of the Journal of the American Society of Nephrology, "the type of drug treatment used to prevent organ rejection in kidney transplant patients doesn't affect cancer risk." Researchers arrived at this conclusion ...

Obese Children May Metabolize Common Medications At Different Rates Than Leaner Children.

According to a study presented at the Experimental Biology annual meeting, "children who are obese appear to metabolize common medications at different rates than their leaner counterparts." After "evaluating the metabolism of active ingredients found ...

Risk For Low-Dose Aspirin-Associated Peptic Ulcer May Be Higher In Elderly Women.

The risk for low-dose aspirin (LDA)-associated peptic ulcer is higher in elderly women," according to a study in the World Journal of Gastroenterology that included 453 patients who underwent esophagogastroduodenoscopy. ...

More at http://www.pharm-education.com/2010/05/risk-for-low-dose-aspirin-associated.html

Disclaimer- The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Http://www.drshrutibhat.comExpert at leading Pharmaceutical R&D.
Translates innovative concepts to PROFITS.
YouTube Channel : Http://www.youtube.com/user/ShrutiBhat10

Do you have questions for the author?

 


Comments




Leave a Reply

     

    The pharmaceutical business is yet another dynamic venture, present globally and extremely important to research scientists, investors and the entire community at large.

    As in any other business, the success of any pharma company lies on 2 factors- investment potential and risk taking ability. In addition, the R&D portfolio becomes a huge numerator to ensure successful profit quotient. 
     

    So what efforts go behind the scene till a new drug hits the market? Do patients benefit ? Are they cured? How do we control health care costs? What are the new drugs in the making?

    To know more, visit-

    http://www.drugsinthemaking.com

    Dr.Shruti Bhat, an Expert in Pharmaceutical industry, brings to you some highlights from current pharma and clinical research news, views and data.

    Details of Shruti's achievements are available on her web portfolio-
    http://www.drshrutibhat.com

    View my profile on LinkedIn

    Archives

    August 2010
    June 2010
    May 2010
    April 2010
    March 2010
    February 2010
    January 2010
    December 2009
    November 2009
    October 2009

    Categories

    All
    Drug Research Updates

    RSS Feed